Skip to content
Screener

Boston Scientific BSX Q1 2026 earnings

Reported April 22, 2026 · Before market open

Revenue$5.2BBeat by $30.1M
EPS$0.80Beat by $0.01
Revenue estimate$5.2B
EPS estimate$0.79

Next report

Oct 28, 2026 (In 3 weeks)
Revenue estimate$5.1B
EPS estimate$0.77

Financials

Q1 2026

Income statement

See full
Revenue$5.2B+11.6%
Gross profit$3.6B+12.6%
Operating income$1.1B+19.5%
Net income$1.3B+99.3%
EPS (diluted)$0.90+100%

Balance sheet

See full
Cash & equivalents$850.0M+146%
Total equity$25.9B+16.4%
Total assets$44.4B+10.5%

Cash flow

See full
Operating cash flow$348.0M-35.7%
CapEx$177.0M-5.3%
Free cash flow$171.0M-51.7%

Valuation & ratios

Valuation

as of 03/31/26
See full
Market cap$93.26B-37.5%
P/E26.2×-47.5×
P/S4.5×-4.0×

Profitability

See full
Gross margin69.2%+0.5pp
Operating margin18.4%+2.2pp
Net margin17.3%+5.7pp
FCF margin16.9%-0.3pp

Returns & leverage

See full
Return on equity14.8%+5.2pp
Current ratio1.9×+0.4×

Segments

By product

See full
Interventional Cardiology & Vascular Therapies$1.2B—
Electrophysiology$905.0M+24.0%
Endoscopy$736.0M+9.4%
Urology$646.0M+2.1%
Cardiac Rhythm Management$578.0M0.0%

By geography

See full
Europe, Middle East and Africa$932.0M+10.2%
Asia-Pacific$803.0M+14.6%
Latin America and Canada$185.0M+19.4%

By segment

See full
Cardiovascular$3.5B+13.5%
MedSurg$1.7B+7.9%

FAQ

When did Boston Scientific report Q1 2026 earnings?
Boston Scientific (BSX) reported Q1 2026 earnings on April 22, 2026 before market open.
What were Boston Scientific's Q1 2026 revenue and EPS?
Boston Scientific reported revenue of $5.2B and eps of $0.80 for Q1 2026.
Did Boston Scientific beat estimates in Q1 2026?
Revenue beat the consensus estimate of $5.2B by $30.1M. EPS beat the consensus estimate of $0.79 by $0.01.
How did Boston Scientific's Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 11.6% from $4.7B a year earlier and eps grew 6.7% from $0.75.
Where can I find Boston Scientific's Q1 2026 SEC filings?
You can read the 8-K earnings release (0000885725-26-000031) and the 10-Q periodic report (0000885725-26-000033) directly on SEC EDGAR. The filing index links above go to sec.gov.